-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Reclassifying Myelodysplastic Syndromes: What's Where in the New WHO and Why

Program: Education Program
Session: Myelodysplastic Syndromes: Evolving Diagnosis and Therapy
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Valencia D (W415D), Level 4 (Orange County Convention Center)
Sunday, December 6, 2015, 7:30 AM-9:00 AM
Valencia D (W415D), Level 4 (Orange County Convention Center)

Daniel A. Arber, MD

Pathology, Stanford University Medical Center, Stanford, CA

Disclosures: Arber: Celgene: Consultancy .

See more of: Myelodysplastic Syndromes: Evolving Diagnosis and Therapy
See more of: Education Program
Previous Presentation | Next Presentation >>